• Return to Headlines

Neurocrine Biosc Down 26.2% Since SmarTrend Downtrend Call (NBIX)

By Shiri Gupta

SmarTrend identified a Downtrend for Neurocrine Biosc (NASDAQ:NBIX) on October 5th, 2018 at $115.36. In approximately 2 months, Neurocrine Biosc has returned 26.15% as of today's recent price of $85.19.

In the past 52 weeks, Neurocrine Biosc share prices have been bracketed by a low of $68.22 and a high of $126.98 and are now at $85.19, 25% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 1.9%.

Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Neurocrine Biosc.

Log in and add Neurocrine Biosc (NBIX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights neurocrine biosc

Ticker(s): NBIX